Literature DB >> 8542582

Aromatic DNA adducts in adjacent tissues of breast cancer patients: clues to breast cancer etiology.

D Li1, M Wang, K Dhingra, W N Hittelman.   

Abstract

The etiology of the majority of human breast cancers is unknown. Environmental factors have long been suspected to play a role, but no specific causative agent has been identified. If the hypothesis that environmental carcinogen exposure contributes to human breast cancer is true, carcinogen-DNA adducts would be expected to be present in human breast tissues. To address this possibility, aromatic DNA adducts were measured in 87 surgical specimens of normal human breast tissues from 87 breast cancer patients undergoing mastectomy using the nuclease P1-enhanced version of the 32P postlabeling assay. Breast tissue samples from 29 noncancer patients undergoing reduction mammoplasty served as controls. Whereas aromatic DNA adducts were detected in all tissue samples examined, the total adduct levels in cancer patients were significantly higher than that in noncancer controls [mean +/- SEM, 97.4 +/- 23.4/10(9) nucleotides (range, 3.8-1737.1) versus 18.1 +/- 11.6/10(9) nucleotides (range, 5.6-56.7), respectively; P < 0.01, t test and Mann-Whitney test]. This difference was not affected by the age distribution of the two groups. The typical smoking-related DNA adduct pattern (i.e., a diagonal radioactive zone) was observed in 29 of 87 tissues (17 of 17 current smokers, 5 of 8 former smokers, 4 of 52 nonsmokers, and 3 of 10 patients with unknown smoking status) and in 2 of 10 control tissues. It was of interest that a benzo(a)pyrene (BP)-like DNA adduct was observed in 36 normal adjacent breast tissues (41%), 27 of which were from nonsmokers. Levels of this BP-like adduct were extremely high (> 100/10(9) nucleotides) in 5 patients (4 nonsmokers and 1 smoker) and moderately high (> 10/10(9) nucleotides) in 13 other patients (8 nonsmokers and 5 smokers). One patient exhibited this adduct at a level of 1500/10(9) nucleotides, which is comparable to the highest level of total adducts reported in human tissues related to carcinogen exposure (e.g., cigarette smoking). In contrast, this adduct was absent (< 1/10(9) nucleotides) in all of the control tissues. Cochromatography and rechromatography analysis of DNA samples from human breast tissues and from MCF-7 cells treated with BP revealed that this adduct could be generated by BP exposure but is not the major BP 7,8-diol-9,10-epoxide-deoxyguanine adduct detected previously in animal tissues and human mammary epithelial cells. These findings support the hypothesis that environmental carcinogen exposure, in addition to cigarette smoking, may be associated with the etiology of human breast cancer.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8542582

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  47 in total

1.  Is there an association between passive smoking and breast cancer?

Authors:  S A Khuder; V J Simon
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

2.  Detection of estrogen DNA-adducts in human breast tumor tissue and healthy tissue by combined nano LC-nano ES tandem mass spectrometry.

Authors:  J Embrechts; F Lemière; W Van Dongen; E L Esmans; P Buytaert; E Van Marck; M Kockx; A Makar
Journal:  J Am Soc Mass Spectrom       Date:  2003-05       Impact factor: 3.109

3.  Role of mammary epithelial and stromal P450 enzymes in the clearance and metabolic activation of 7,12-dimethylbenz(a)anthracene in mice.

Authors:  Yang Lin; Yunyi Yao; Senyan Liu; Lihua Wang; Bhagavatula Moorthy; Dongsheng Xiong; Tao Cheng; Xinxin Ding; Jun Gu
Journal:  Toxicol Lett       Date:  2012-05-15       Impact factor: 4.372

4.  Geographic variations in female breast cancer incidence in relation to ambient air emissions of polycyclic aromatic hydrocarbons.

Authors:  Courtney Large; Yudan Wei
Journal:  Environ Sci Pollut Res Int       Date:  2017-06-14       Impact factor: 4.223

5.  The development of molecular epidemiology to elucidate cancer risk and prognosis: a historical perspective.

Authors:  Christine B Ambrosone; Curtis C Harris
Journal:  Int J Mol Epidemiol Genet       Date:  2010-02-20

6.  Basal levels of DNA damage detected by micronuclei and comet assays in untreated breast cancer patients and healthy women.

Authors:  Raquel A Santos; Ana Cláudia Teixeira; Monica B Mayorano; Hélio H A Carrara; Jurandyr M Andrade; Catarina S Takahashi
Journal:  Clin Exp Med       Date:  2009-11-10       Impact factor: 3.984

7.  Polycyclic aromatic hydrocarbon-DNA adducts and survival among women with breast cancer.

Authors:  Sharon K Sagiv; Mia M Gaudet; Sybil M Eng; Page E Abrahamson; Sumitra Shantakumar; Susan L Teitelbaum; Paula Bell; Joyce A Thomas; Alfred I Neugut; Regina M Santella; Marilie D Gammon
Journal:  Environ Res       Date:  2009-01-31       Impact factor: 6.498

8.  Weight History, Smoking, Physical Activity and Breast Cancer Risk among French-Canadian Women Non-Carriers of More Frequent BRCA1/2 Mutations.

Authors:  Vishnee Bissonauth; Bryna Shatenstein; Eve Fafard; Christine Maugard; André Robidoux; Steven Narod; Parviz Ghadirian
Journal:  J Cancer Epidemiol       Date:  2009-04-16

9.  In vitro evaluation of baseline and induced DNA damage in human sperm exposed to benzo[a]pyrene or its metabolite benzo[a]pyrene-7,8-diol-9,10-epoxide, using the comet assay.

Authors:  V Sipinen; J Laubenthal; A Baumgartner; E Cemeli; J O Linschooten; R W L Godschalk; F J Van Schooten; D Anderson; G Brunborg
Journal:  Mutagenesis       Date:  2010-05-20       Impact factor: 3.000

10.  PAH-DNA adducts, cigarette smoking, GST polymorphisms, and breast cancer risk.

Authors:  Kathleen M McCarty; Regina M Santella; Susan E Steck; Rebecca J Cleveland; Jiyoung Ahn; Christine B Ambrosone; Kari North; Sharon K Sagiv; Sybil M Eng; Susan L Teitelbaum; Alfred I Neugut; Marilie D Gammon
Journal:  Environ Health Perspect       Date:  2008-12-10       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.